Age at onset of narcolepsy in two large populations of patients in France and Quebec.
about
Stimulant drugs for narcolepsy in adultsEffect of amphetamines on blood pressureStimulant drugs for narcolepsy in adultsStimulant drugs for narcolepsy in adultsEffect of amphetamines on blood pressureAntidepressant drugs for narcolepsyAntidepressant drugs for narcolepsyTreatment paradigms for cataplexy in narcolepsy: past, present, and futurePharmacotherapy options for cataplexyIncreased risk of narcolepsy in children and adults after pandemic H1N1 vaccination in France.No serological evidence of influenza A H1N1pdm09 virus infection as a contributing factor in childhood narcolepsy after Pandemrix vaccination campaign in Finland.Explorations of clinical trials and pharmacovigilance databases of MF59®-adjuvanted influenza vaccines for associated cases of narcolepsy.Clinical and polysomnographic course of childhood narcolepsy with cataplexy.Neuroimaging findings in narcolepsy with cataplexy.CD8 T cell-mediated killing of orexinergic neurons induces a narcolepsy-like phenotype in mice.Effectiveness of risk management plans: a case study of pemoline using pharmacy claims data.Association of narcolepsy-cataplexy with HLA-DRB1 and DQB1 in Mexican patients: a relationship between HLA and gender is suggested.Elevated Tribbles homolog 2-specific antibody levels in narcolepsy patientsQuantitative analysis of age specific variation in the abundance of human female parotid salivary proteins.Increased immune complexes of hypocretin autoantibodies in narcolepsy.The development of a health-related quality-of-life instrument for young people with narcolepsy: NARQoL-21Low vitamin D in narcolepsy with cataplexy.Differential diagnosis in hypersomnia.Hypersomnia and depressive symptoms: methodological and clinical aspectsPresentations of primary hypersomnia in Chinese children.Narcolepsy: current treatment options and future approachesHealth-related stigma as a determinant of functioning in young adults with narcolepsy.Complex movement disorders at disease onset in childhood narcolepsy with cataplexy.Clinical and neurobiological aspects of narcolepsy.REM sleep characteristics in narcolepsy and REM sleep behavior disorderPredictors of hypocretin (orexin) deficiency in narcolepsy without cataplexyNormal cerebrospinal fluid histamine and tele-methylhistamine levels in hypersomnia conditionsCentral Disorders of Hypersomnolence: Focus on the Narcolepsies and Idiopathic Hypersomnia.Molecular genetics and treatment of narcolepsy.Smoking, Alcohol, Drug Use, Abuse and Dependence in Narcolepsy and Idiopathic Hypersomnia: A Case-Control StudyNarcolepsy: immunological aspects.Prevalence of narcolepsy in King County, Washington, USA.The impact of gender on timeliness of narcolepsy diagnosisEvaluation of Quality of Life in Patients With Narcolepsy Treated With Sodium Oxybate: Use of the 36-Item Short-Form Health Survey in a Clinical Trial.Treatment of narcolepsy.
P2860
Q24188240-E7876169-B608-4AA8-812A-DCA2BF3F8062Q24201086-37EC83A4-6D9F-440C-B491-C3F72A36FE39Q24202567-43438EC0-E864-4F5D-8C78-675F2F17DB71Q24240320-7E3313DB-8589-4FA8-9F01-4EE1C67A441CQ24240569-750D7EA9-4E9E-4E00-AAFB-917015253BBCQ24242527-BEE4E56C-B0FC-4E31-8D81-4BBA7287ED16Q24246597-134AC592-9120-47DA-8342-C9A62C8AA7F2Q26771634-159C8C80-AF70-472F-84AB-DE4C5533CD98Q28287690-9D03CC97-2B62-4DAA-BCCE-939E2C36063DQ30352315-500E8065-BB68-447D-A1D8-571B7BDD0A8BQ30352889-7A75B022-B05A-4C65-9FE5-36906EE7188EQ30402238-0844A163-FFD8-4C66-A2BF-C2EF6BBEA929Q30559262-C240B69F-42DB-450F-BBF6-0910AED354C1Q30606609-C50C33B6-2511-4F2D-9081-0531E6C74E6FQ30818202-F608679D-8160-4DE4-A3A8-8FABC4C8C575Q31047942-D5EAA737-A49A-4DB5-B170-A86975D46BBAQ33360439-3C2E5E61-7802-4F66-8BA3-E7D657F43B8EQ33685660-91D52458-7787-48EB-BBD5-55CE72A725C8Q33712649-BF14E38D-2CD7-42CF-BB84-3171E4D85B66Q33725437-922098C5-B557-4B18-AAF7-8E06B5B57DF6Q33868800-597F8699-CDF1-41DA-B919-EBCACB1EA4A8Q33919832-0AE9374B-37D4-4EB1-B999-72449E1D85F2Q34500176-7BEE875C-405C-4D91-BE36-D183DA62EFBAQ34628648-5E5183D5-DB1F-48FA-9DB0-7B397E173AA4Q34821484-3DED3042-1E37-4B4C-B832-ABA5A849528DQ34843237-443F9C9A-F32A-4A7B-9CB6-ED7BAFCDCBCDQ35512708-8580263B-625C-4DE2-849A-A3A1DB1D640FQ35606698-D7259F13-820C-44ED-B705-1B6EAB9A769AQ35995182-52C61593-C01B-4C6F-8282-075519EB627DQ35995496-29364069-38D9-4CFF-BD38-DC6EA6B452E5Q36147074-E7152F27-7A1C-4874-BBB3-9CDB368EBB35Q36238099-5472DCE5-BF75-4A7D-8F0E-CD53FCB51389Q36411331-0434D55C-DDA4-4E8E-9837-1BE803BC0767Q36497536-FE45FE2B-00B8-47BA-929B-36F2CDC6E416Q36606342-36A7F819-C598-4390-8902-8713E37B3B0CQ37091394-6530A1FD-A4B4-4CBA-A7ED-64A330A21F84Q37368887-4FC05E38-C241-420A-8118-109C49950B2FQ37405862-DA85CE83-B74D-40E9-A744-7DB0AF142A35Q37459093-6E6ADBFE-C305-463C-8F6A-F1E57957E572Q37507989-5749F8D2-FB78-49B5-AB78-73A1A3AC61F5
P2860
Age at onset of narcolepsy in two large populations of patients in France and Quebec.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh
2001年學術文章
@zh-hant
name
Age at onset of narcolepsy in two large populations of patients in France and Quebec.
@en
Age at onset of narcolepsy in two large populations of patients in France and Quebec.
@nl
type
label
Age at onset of narcolepsy in two large populations of patients in France and Quebec.
@en
Age at onset of narcolepsy in two large populations of patients in France and Quebec.
@nl
prefLabel
Age at onset of narcolepsy in two large populations of patients in France and Quebec.
@en
Age at onset of narcolepsy in two large populations of patients in France and Quebec.
@nl
P2093
P356
P1433
P1476
Age at onset of narcolepsy in two large populations of patients in France and Quebec
@en
P2093
B Carlander
J Montplaisir
M Billiard
N Molinari
P304
P356
10.1212/WNL.57.11.2029
P407
P577
2001-12-01T00:00:00Z